Andrea Dalbeni
Overview
Explore the profile of Andrea Dalbeni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
926
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dalbeni A, Cattazzo F, De Marco L, Bevilacqua M, Zoncape M, Lombardi R, et al.
Dig Liver Dis
. 2023 Dec;
56(2):379-380.
PMID: 38065697
No abstract available.
12.
Dalbeni A, Lombardi R, Henrique M, Zoncape M, Pennisi G, Petta S, et al.
Hepatology
. 2023 Nov;
79(5):1107-1116.
PMID: 37976417
Background And Aims: A simple noninvasive score, the Agile 3+ score, combining liver stiffness measurement, aspartate aminotransferase/alanine aminotransferase ratio, platelet count, diabetes status, sex, and age, has been proposed for...
13.
Dalbeni A, Garbin M, Zoncape M, Romeo S, Cattazzo F, Mantovani A, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958820
Glomerular hyperfiltration (GH) is an increase in the glomerular filtration rate, possibly progressing to chronic kidney disease (CKD). Metabolic-associated steatotic liver disease (MASLD) is linked to an increased risk of...
14.
Dalbeni A, Cattazzo F, De Marco L, Bevilacqua M, Zoncape M, Lombardi R, et al.
Dig Liver Dis
. 2023 Oct;
56(3):477-483.
PMID: 37778894
Background: Portal vein thrombosis (PVT) and sepsis are common complications in patients with liver cirrhosis. Factors that lead to PVT are not completely understood. This study aimed to investigate the...
15.
Dalbeni A, Kumar R, Albhaisi S
Front Endocrinol (Lausanne)
. 2023 Sep;
14:1267341.
PMID: 37772079
No abstract available.
16.
Sibani M, Canziani L, Tonolli C, Armellini M, Carrara E, Mazzaferri F, et al.
Antibiotics (Basel)
. 2023 Jun;
12(6).
PMID: 37370328
Background: Since the SARS-CoV-2 pandemic emerged, antimicrobial stewardship (AS) activities need to be diverted into COVID-19 management. Methods: In order to assess the impact of COVID-19 on AS activities, we...
17.
Zoncape M, Carlin M, Bicego M, Simonetti A, Ceruti V, Mantovani A, et al.
Intern Emerg Med
. 2023 Jun;
18(7):2063-2073.
PMID: 37268769
Patients with COVID-19 and metabolic-dysfunction associated fatty liver disease (MAFLD) appear to be at higher risk for severe manifestations, especially in the youngest decades. Our aim was to examine whether...
18.
Bevilacqua M, De Marco L, Stupia R, Dima F, Cattazzo F, Paon V, et al.
Intern Emerg Med
. 2023 May;
18(5):1397-1404.
PMID: 37212944
Chronic anaemia in advanced liver disease is a frequent finding. The aim was to explore the clinical impact of spur cell anaemia, a rare entity typically associated with end-stage of...
19.
Dalbeni A, Natola L, Garbin M, Zoncape M, Cattazzo F, Mantovani A, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37173873
Hepatocellular carcinoma (HCC) is the major cause of liver-related death worldwide. Interleukin 6 (IL-6) promotes the growth of the HCC microenvironment. The correlation between Child-Pugh (CP) and HCC stage and...
20.
Mantovani A, Dalbeni A
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108404
The aim of the second edition of our Special Issue, entitled .